These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6941434)

  • 1. Coagulation quality control surveys in France.
    Goguel AF; Houbouyan LL; Roussi JH
    Scand J Haematol Suppl; 1980; 37():150-2. PubMed ID: 6941434
    [No Abstract]   [Full Text] [Related]  

  • 2. Preanalytical Variables on Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen.
    Joob B; Wiwanitkit V
    Clin Lab; 2016 Jul; 62(7):1379. PubMed ID: 28164643
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory control of anticoagulant therapy.
    Poller L
    Semin Thromb Hemost; 1986 Jan; 12(1):13-9. PubMed ID: 3961505
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardization of laboratory tests for controlling anticoagulent therapy.
    Zucker S; Cathey MH; Sox PJ; Hall EC
    Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
    [No Abstract]   [Full Text] [Related]  

  • 6. [IMPORTANCE OF THE THROMBOTEST. II. A COMPARATIVE STUDY OF THE THROMBOTEST, THROMBOPLASTIN TIME AND PARTIAL THROMBOPLASTIN TIME].
    FREDERIKS PW
    Ned Tijdschr Geneeskd; 1964 Jan; 108():156-61. PubMed ID: 14135805
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of "Statsep," a semiautomated device to prepare plasma samples for coagulation analysis.
    Hoppensteadt D; Walenga JM; Fareed J; Phelan K
    Semin Thromb Hemost; 1983 Oct; 9(4):334-40. PubMed ID: 6658464
    [No Abstract]   [Full Text] [Related]  

  • 8. The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency.
    Abildgaard A; Hvas AM
    Clin Chem Lab Med; 2021 Jun; 59(7):e297-e300. PubMed ID: 33544482
    [No Abstract]   [Full Text] [Related]  

  • 9. Summary evaluation of the Sysmex CA-6000 coagulation analyzer.
    Gosselin RC; Owings JT; Larkin E; Cannon J
    Clin Chem; 1997 Sep; 43(9):1783-5. PubMed ID: 9299977
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of standardization in the biological monitoring of anti-vitamin K therapy].
    Forestier F; Boneu B; Potron G; Boisseau M; Coqueret B; Saffar S; Chambrette B
    Nouv Rev Fr Hematol (1978); 1986; 28(3):157-62. PubMed ID: 3748800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association.
    Pai M; Moffat KA; Plumhoff E; Hayward CP
    Am J Clin Pathol; 2011 Dec; 136(6):836-41. PubMed ID: 22095367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation tests ].
    Fukue H; Fukutake K
    Rinsho Byori; 1997 Nov; Suppl():99-106. PubMed ID: 9508613
    [No Abstract]   [Full Text] [Related]  

  • 13. Calibration of five different thromboplastins, using fresh and freeze-dried plasma.
    Bangham DR; Biggs R; Brozović M; Denson KW
    Thromb Diath Haemorrh; 1973 May; 29(2):228-39. PubMed ID: 4796944
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100].
    Barbe D; Bauduer F; Tanguy A
    Ann Biol Clin (Paris); 1991; 49(10):507-13. PubMed ID: 1807170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation studies in patients with marked thrombocytopenia due to severe preeclampsia.
    Prieto JA; Mastrobattista JM; Blanco JD
    Am J Perinatol; 1995 May; 12(3):220-2. PubMed ID: 7612100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the automated coagulation analyzer SYSMEX CA 6000.
    Quehenberger P; Kapiotis S; Handler S; Ruzicka K; Speiser W
    Thromb Res; 1999 Oct; 96(1):65-71. PubMed ID: 10554086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of specimen collection on routine coagulation assays and D-dimer measurement.
    Lippi G; Guidi GC
    Clin Chem; 2004 Nov; 50(11):2150-2. PubMed ID: 15502084
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
    Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
    [No Abstract]   [Full Text] [Related]  

  • 20. Automated clot-based methods in coagulation testing: current and future considerations.
    Walenga JM; Hoppensteadt D; Fareed J; Silberman S; Shelvin P
    Semin Thromb Hemost; 1983 Oct; 9(4):245-9. PubMed ID: 6658458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.